Advertisement
U.S. markets open in 6 hours 28 minutes

Haemonetics Corporation (HAE)

NYSE - NYSE Delayed Price. Currency in USD
75.79+0.97 (+1.30%)
At close: 04:00PM EDT
76.83 +1.04 (+1.37%)
After hours: 07:47PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close74.82
Open75.19
Bid0.00 x 900
Ask0.00 x 1100
Day's Range74.62 - 76.13
52 Week Range70.74 - 95.26
Volume442,451
Avg. Volume438,936
Market Cap3.849B
Beta (5Y Monthly)0.34
PE Ratio (TTM)30.81
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-3% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HAE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Haemonetics Corporation
    HAE: Raising target price to $81.00HAEMONETICS CORP/MASS has an Investment Rating of HOLD; a target price of $81.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more